NG-004

N/A

Report date: 2025/02/12 20:00:40

Base Information

Drug NameNG-004
Drug Alias NameNG-004
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionReticulon-4 inhibitors
TargetsReticulon-4
Therapy Area/IndicationsWounds and InjuriesTrauma, Nervous SystemSpinal Cord Injuries +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanySwitzerland
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNovaGo Therapeutics AG
China Registration ClassN/A

Develop Information

Active CompaniesNovaGo Therapeutics AGNeurimmune Ag
Inactive CompaniesN/A
Active IndicationsTrauma, Nervous SystemSpinal Cord InjuriesSpinal Cord Diseases +[5] 
Inactive IndicationsWounds and InjuriesNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A